Cargando…
221 Changes in Emergency Department Visits for Opioid-Related Diagnosis, Opioid Overdose and Buprenorphine Use Across 14 US Emergency Departments During the SARS-CoV-2 Pandemic
Autores principales: | ED INNOVATION Research Group, Hawk, K., Taylor, A., Phadke, M., Li, F., Dziura, J., Perrone, J., McCormack, R., Herring, A., Cowan, E., Fiellin, D., D'Onofrio, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536288/ http://dx.doi.org/10.1016/j.annemergmed.2021.09.233 |
Ejemplares similares
-
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021) -
Emergency department‐initiated buprenorphine protocols: A national evaluation
por: Guo, Clara Z., et al.
Publicado: (2021) -
Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
por: D’Onofrio, Gail, et al.
Publicado: (2023) -
Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023) -
Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017
por: Rhee, Taeho Greg, et al.
Publicado: (2020)